Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
By P. Tamma, S. Cosgrove, L. Maragakis. Clinical Microbiology Reviews, 2012
727 citations recorded by the source corpus.
Subfields: Clinical Biochemistry, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/08ce54f79b2e323c05628ad39cfed49a57290ea9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Medicine
In Pharmacology
Citations in the corpus
- Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges (2016, background): “resistance in vivo, particularly for Gram-negative bacterial infections (268, 270, 271).”
- Aminoglycosides: An Overview. (2016, background): “In patients with serious infections caused by Gram-negative pathogens, the receipt of empiric combination therapy containing at least one antimicrobial agent to which the pathogen is susceptible leads to lower mortality and improved outcomes (Tamma et al. 2012).”